Refine
Year of publication
- 2005 (57) (remove)
Document Type
- Doctoral Thesis (57) (remove)
Language
- English (57) (remove)
Has Fulltext
- yes (57)
Is part of the Bibliography
- no (57)
Keywords
- Doxorubicin (2)
- 15d-PGJ2 (1)
- 3D-Modellierung (1)
- 5-lipoxygenase (1)
- ABC-Transporter (1)
- ABC-transporter (1)
- ALICE (1)
- ALTRO (1)
- ATPase (1)
- Absorptionsspektroskopie (1)
Institute
- Biochemie und Chemie (19)
- Physik (15)
- Pharmazie (11)
- Biowissenschaften (7)
- Geowissenschaften (2)
- Biochemie, Chemie und Pharmazie (1)
- Informatik (1)
- Psychologie (1)
Systematisch verabreichte Chemotherapeutika sind oft uneffektiv bei der Behandlung von Krankheiten des zentralen Nervensystems (ZNS). Eine der Ursachen hierfür ist der unzureichende Arzneistoff-Transport ins Gehirn aufgrund der Blut-Hirn-Schranke. Eine der Strategien für den nicht-invasiven Wirkstoff-Transport ins Gehirn ist die Verwendung von Nanopartikeln. Polybutylcyanoacrylat-Nanopartikel, die mit Polysorbat 80 (Tween® 80) überzogen wurden, können die Blut-Hirn-Schranke passieren und somit Wirkstoffe ins Gehirn transportieren. Wird die Blut-Hirn-Schranke durch einen Hirntumor partiell beschädigt und hierdurch ihre Permeabilität am Ort des Tumors erhöht, können Nanopartikel den Tumor zusätzlich durch den sogenannten EPR-Effekt erreichen. Im ersten Teil der vorliegenden Arbeit wurde die Beladung der Nanopartikel durch Variation der Formulierungparameter mit dem Ziel optimiert, eine Formulierung mit höherer Wirksamkeit für die Therapie von Glioblastom-tragenden Ratten zu entwickeln. Außerdem wurde das Potential von Doxorubicin, das an mit „Stealth Agents“ überzogenen Polybutylcyanoacrylat-Nanopartikel gebunden war, für die Chemotherapie von Hirntumoren untersucht. Im zweiten Teil dieser Studie wurden die Gehirn- und Körperverteilung in gesunden und in Glioblastom-101/8-tragenden Ratten nach i.v.-Gabe von Poly(butyl-2-cyano[3- 14C]acrylat)-Nanopartikeln, die mit Polysorbat 80 beschichtet wurden, und solchen, die noch zusätzlich mit Doxorubicin geladen waren (DOX-14C-PBCA + PS), untersucht. Die Standardformulierung von Doxubicin-Polybutylcyanoacrylat-Nanopartikeln (DOX-NP) wurde durch anionische Polymerisierung von Butylcyanoacrylat in Anwesenheit von DOX hergestellt. Zusätzlich wurden unterschiedliche DOX-NP Formulierungen durch Veränderung der Herstellung produziert. Das therapeutische Potential der Formulierungen wurde in Ratten mit ins Gehirn transplantieren Glioblastom 101/8 untersucht. Neben Polysorbat 80 wurden Poloxamer 188 und Poloxamin 908 als Überzugsmaterial verwendet. Die Resultate ergaben, dass die mit Polysorbat 80 überzogene Standardformulierung am effektivsten war. Die höhere Wirksamkeit von DOX-NP+PS 80 könnte durch die Fähigkeit dieser Träger erklärt werden, den Wirkstoff während eines frühen Stadiums der Tumorentwicklung durch einen Rezeptor-vermittelten Mechanismus, der durch den PS 80-Überzug aktiviert wurde über die intakte Blut-Hirn-Schranke, zu transportieren. Unsere Ergebnisse zeigen auch, dass Poloxamer 188 und Poloxamin 908 den antitumoralen Effekt von DOX-PBCA beträchtlich verbessern. Der anti-tumorale Effekt dieser Formulierungen könnte möglicherweise dem EPR-Effekt zugeschrieben werden. Es ist bekannt, dass die tumorale Arzneistoff-Aufnahme durch den EPR-Effektes für lang-zirkulierende Wirkstoffträger ausgeprägter ist und so mehr Wirkstoff durch die Tumor-geschädigte Blut-Hirn-Schranke gelangt. Unbeschichtete Nanopartikel, Polysorbat 80-beschichtete Nanopartikel oder mit Doxorubicin beladene und mit Polysorbat 80 beschichtete Nanopartikel wurden in gesunden und Tumor-tragenden Ratten injiziert. Diese Nanopartikel-Präparationen zeigten einer unterschiedliche Korpenverteilung in den Ratten. Unbeschichtete Nanopartikel sammelten sich in den RES-Organen an. Mit PS 80 beschichtete NP reduzierten die Aufnahme der NP in Leber und Milz, während sich die Konzentration der NP in der Lunge erhöhte. Diese Beobachtungen deuten darauf hin, dass die Änderung der Oberflächeneigenschaften der NP durch das Tensid, zu einer Interaktion mit unterschiedlichen Opsoninen führt, welches die Aufnahme der NP von verschiedenen phagozitierenden Zellen erleichtert. Hingegen war die Aufnahme der mit DOX beladenen, PS 80-beschichteten Nanopartikel den unbeschichteten Partikel ähnlich. Im Vergleich mit gesunden Ratten und mit Tumor-tragenden Ratten hingegen war die Konzentration der NP im Gehirn von Tumor tragenden Ratten 10 Tage nach der Tumor-implantation signifikant höher. In Anwesenheit des Glioblastoms ist der Transport von NP in das Gehirn das Resultat verschiedener Faktoren: zusätzlich zur Fähigkeit von PS 80-Nanopartikeln, die Blut-Hirn-Schranke zu passieren, extravasieren diese Träger wegen des EPR Effekts über das durch den Tumor undichte Endothelium. Die Konzentration von PS 80 [14C]-PBCA NP war im Glioblastom signifikant höher als mit DOX [14C]-PBCA NP. Dieses Phänomen kann durch die unterschiedliche Mikroumgebung von zerebralem intra-tumoralen und intaktem Gehirngewebe erklärt werde. Insbesondere können sich die positive Ladung der tumoralen Regionen und die positive Ladung der DOX [14C]-PBCA NP negativ beeinflussen. Dennoch waren die Doxorubicin-Konzentration in Glioblastom ausreichend, einen therapeutischen Effekt zu ermöglichen.
The analysis of doxorubicin-loaded poly(butyl cyanoacrylate) nanoparticles in in vitro glioma models
(2005)
The use of doxorubicin for the treatment of glioma tumours would be an important approach in the chemotherapy treatment since doxorubicin is a very effective neoplastic agent. However, one problem faced by the use of doxorubicin for the treatment of brain tumours is the fact that doxorubicin is a substrate of an efflux pump protein, P-glycoprotein (P-gp), which is located on the luminal side of the brain capillary endothelium and in many tumour cells, which acts pumping out of the cell such substrate, and blocking its transport into the cell. A strategy to enhance the doxorubicin delivery into the brain would be the use of nanoparticles. This work showed, that the treatment of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles decreased the viability of the three glioma cell lines, the GS-9L, the RG-2, and the F-98 cell lines significantly in comparison to doxorubicin in solution, indicating an improvement of the nanoparticles-bound doxorubicin transport into the cells. The modification of the nanoparticles surface with different surfactants may even enhance the delivery of the drug into the cells. Searching for an improvement of the doxorubicin internalization, the nanoparticles surface was modified using polysorbate 80, poloxamer 188 and poloxamine 908 surfactants. The poloxamer 188 and polaxamine 908 surfactant modified nanoparticles did not show a significant enhancement of the doxorubicin internalization. Contrary, the treatment of polysorbate 80 surfactant modified nanoparticles led in some cases to a significant decrease of cancer cell viability. The use of doxorubicin in the three glioma cell lines allowed the measurement of different responses towards doxorubicin treatment. The different responses were due to the entry of various amounts of doxorubicin into the glioma cells, which express the P-glycoprotein in their cellular membrane. A higher level of the P-gp expression correlated with a weaker response towards the doxorubicin treatment. The GS-9L cell line showed a significant higher level of P-gp expression than the F-98, and RG-2 cell lines, and consequently, the GS-9L cell line presented the highest resistance to doxorubicin with the highest viability values after doxorubicin treatment. Due to the fact that the transport of doxorubicin is governed by the activity of the P-gp in the studied glioma cells, the use of poloxamer 185 as a P-gp inhibitor resulted in an enhancement of the uptake as well as of the accumulation of doxorubicin into the cells. The effect of poloxamer 185 on the doxorubicin uptake was significant marked in the case of doxorubicin-resistance cells, as the GS-9L cell line. In some cases, the presence of the nanoparticles formulation showed also an influence on such uptake improvement. The use of a P-gp inhibitor in combination with chemotherapeutic agents leads to encouraging results. Because of the wide spectrum of substances acting as P-gp inhibitors, the exact inhibitory mechanisms remain still unclear. For instance in our results the evaluation of a described P-gp inhibitor, polysorbate 80 did not show an important improvement in the doxorubicin uptake in the P-gp-expressing cell line, GS-9L. On the other hand, the Polysorbate 80-Dox-PBCA nanoparticles formulation decreased in greater extend the viability of the glioma cells than the poloxamer185-Dox-PBCA nanoparticles. Although, the P-gp inhibition was undoubtedly higher in the presence of poloxamer 185, polysorbate 80 showed a main effect on the disruption of the cellular membrane, resulting in an important cellular viability decrease. It seems that poloxamer 185 presents a direct effect on the functionality of the P-gp protein, which would be of great importance in the sensitization of resistant cancer cells. The range of concentration of poloxamer 185 is very important to yield an inhibitory effect on the P-gp-mediated transport mechanism. The accumulation of Rhodamine-123 (Rho-123), a known P-gp substrate, increased in a range of concentration from 0.001 % to 0.01, whereas at 0.1 % poloxamer 185 the accumulation significantly decreased. A maximal Rho-123 accumulation was reached at 0.01 % poloxamer 185.
In the classical Dirac equation with strong potentials, called overcritical, a bound state reaches the negative continuum. In QED the presence of a static overcritical external electric field leads to a charged vacuum and indicates spontaneous particle creation when the overcritical field is switched on. The goal of this work is to clarify whether this effect exists, i.e. if it can be uniquely defined and proved, in time-dependent physical processes. Starting from a fundamental level of the theory we check all mathematical and interpretational steps from the algebra of fields to the very effect. In the first, theoretical part of this thesis we introduce the mathematical formulation of the classical and quantized Dirac theory with their most important results. Using this language we define rigorously the notion of spontaneous particle creation in overcritical fields. First, we give a rigorous definition of resonances as poles of the resolvent or the Green's function and show how eigenvalues become resonances under Hamiltonian perturbations. In particular, we consider essential for overcritical potentials perturbation of eigenvalues at the edge of the continuous spectrum. Next, we gather various adiabatic theorems and discuss well-posedness of the scattering in the adiabatic limit. Then, we construct Fock space representations of the field algebra, study their equivalence and give a unitary implementer of all Bogoliubov transformations induced by unitary transformations of the one-particle Hilbert space as well as by the projector (or vacuum vector) changes as long as they lead to unitarily equivalent Fock representations. We implement in Fock space self-adjoint and unitary operators from the one-particle space, discussing the charge, energy, evolution and scattering operators. Then we introduce the notion of particles and several particle interpretations for time-dependent processes with a different Fock space at every instant of time. We study how the charge, energy and number of particles change in consequence of a change of representation or in implemented evolution or scattering processes, what is especially interesting in presence of overcritical potentials. Using this language we define rigorously the notion of spontaneous particle creation. Then we look for physical processes which show the effect of vacuum decay and spontaneous particle creation exclusively due to the overcriticality of the potential. We consider several processes with static as well as suddenly switched on (and off) static overcritical potentials and conclude that they are unsatisfactory for observation of the spontaneous particle creation. Next, we consider properties of general time-dependent scattering processes with continuous switch on (and off) of an overcritical potential and show that they also fail to produce stable signatures of the particle creation due to overcriticality. Further, we study and successfully define the spontaneous particle creation in adiabatic processes, where the spontaneous antiparticle is created as a result of a resonance (wave packet) decay in the negative continuum. Unfortunately, they lead to physically questionable pair production as the adiabatic limit is approached. Finally, we consider extension of these ideas to non-adiabatic processes involving overcritical potentials and argue that they are the best candidate for showing the spontaneous pair creation in physical processes. Demanding creation of the spontaneous antiparticle in the state corresponding to the overcritical resonance rather quick than slow processes should be considered, with a possibly long frozen overcritical period. In the second part of this thesis we concentrate on a class of spherically symmetric square well potentials with a time-dependent depth. First, we solve the Dirac equation and analyze the structure and behaviour of bound states and appearance of overcriticality. Then, by analytic continuation we find and discuss the behaviour of resonances in overcritical potentials. Next, we derive and solve numerically (introducing a non-uniform continuum discretization for a consistent treatment of narrow peaks) a system of differential equations (coupled channel equations) to calculate particle and antiparticle production spectra for various time-dependent processes including sudden, quick, slow switch on and off of a sub- and overcritical potentials. We discuss in detail how and under which conditions an overcritical resonance decays during the evolution giving rise to the spontaneous production of an antiparticle. We compare the antiparticle production spectrum with the shape of the resonance in the overcritical potential. We study processes, where the overcritical potentials are switched on at different speed and are possibly frozen in the overcritical phase. We prove, in agreement with conclusions of the theoretical part, that the peak (wave packet) in the negative continuum representing a dived bound state partially follows the moving resonance and partially decays at every stage of its evolution. This continuous decay is more intensive in slow processes, while in quick processes the wave packet more precisely follows the resonance. In the adiabatic limit, the whole decay occurs already at the edge of the continuum, resulting in production of antiparticles with vanishing momentum. In contrast, in quick switch on processes with delay in the overcritical phase, the spectrum of the created antiparticles agrees best with the shape of the resonance. Finally, we address the question how much information about the time-dependent potential can be reconstructed from the scattering data, represented by the particle production spectrum. We propose a simple approximation method (master equation) basing on an exponential, decoherent decay of time-dependent resonances for prediction of particle creation spectra and obtain a good agreement with the results of full numerical calculations. Additionally, we discuss various sources of errors introduced by the numerical discretization, find estimations for them and prove convergence of the numerical schemes.
Chemokines play a key role in the cellular infiltration of inflamed tissue. They are released by a wide variety of cell types during the initial phase of host response to injury, allergens, antigens, or invading microorganisms, and selectively attract leukocytes to inflammatory foci, inducing both migration and activation. Monocyte chemoattractant protein-1 (MCP-1), a member of the CC chemokine superfamily, functions in attracting monocytes, T lymphocytes, and basophils to sites of inflammation. MCP-1 is produced by monocytes, fibroblasts, vascular endothelial cells and smooth muscle cells in response to various stimuli such as tumour necrosis factor-a (TNF-a), interferon-g (IFN-g), and interleukin-1b (IL-1b). It also plays an important role in the pathogenesis of chronic inflammation, and overexpression of MCP-1 has been implicated in diseases including glomerulonephritis and rheumatoid arthritis. Oligonucleotide-directed triple helix formation offers a means to target specific sequences in DNA and interfere with gene expression at the transcriptional level. Triple helix-forming oligonucleotides (TFOs) bind to homopurine/homopyrimidine sequences, forming a stable, sequence-specific complex with the duplex DNA. Purine-rich sequences are frequent in gene regulatory regions and TFOs directed to promoter sequences have been shown to prevent binding of transcription factors and inhibit transcription initiation and elongation. Exogenous TFOs that bind homopurine/ homopyrimidine DNA sequences and form triple-helices can be rationally designed, while the intracellular delivery of single-stranded RNA TFOs has not been studied in detail before. In this study, expression vectors were constructed which directed transcription of either a 19 nt triplex-forming pyrimidine CU-TFO sequence targeting the human MCP-1 or two different 19 nt GU- or CA-control sequences, respectively, together with the vector encoded hygromycin resistance mRNA as one fusion transcript. HEK 293 cells were stable transfected with these vectors and several TFO and control cell lines were generated. Functional relevant triplex formation of a TFO with a corresponding 19 bp GC-rich AP-1/SP-1 site of the human MCP-1 promoter was shown. Binding of synthetic 19 nt CUTFO to the MCP-1 promoter duplex was verified by triplex blotting at pH 6.7. Underlining binding specificity, control sequences, including the GU- and CA-sequence, a TFO containing one single mismatch and a MCP-1 promoter duplex containing two mismatches, did not participate in triplex formation. Establishing a magnetic capture technique with streptavidin microbeads it was verified that at pH 7.0 the 19 nt TFO embedded in a 1.1 kb fusion transcript binds to a plasmid encoded MCP-1 promoter target duplex three times stronger than the controls. Finally, cell culture experiments revealed 76 ± 10.2% inhibition of MCP-1 protein secretion in TNF-a stimulated CU-TFO harboring cell lines and up to 88% after TNF-a and IFN-g costimulation in comparison to controls. Expression of interleukin-8 (IL-8) as one TNF-a inducible control gene was not affected by CU-TFO, demonstrating both highly specific and effective chemokine gene repression. Furthermore, another chemokine target, regulated upon activation normal T cell expressed and secreted (RANTES), which plays an essential role in inflammation by recruiting T lymphocytes, macrophages and eosinophils to inflammatory sites, was analysed using the triplex approach. A 28 nt TFO was designed targeting the murine RANTES gene promoter, and gel mobility shift assays demonstrated that the phosphodiester TFO formed a sequencespecific triplex with the double-stranded target DNA with a Kd of 2.5 x 10-7 M. It was analysed whether RANTES expression could be inhibited at the transcriptional level testing the TFO in two different cell lines, T helper-1 lymphocytes and brain microvascular endothelial cells (bend3 cells). Although there was a sequence-specific binding of the TFO detectable in the gel shift assays, there was no inhibitory effect of the exogenously added and phosphorothioate stabilised TFO on endogenous RANTES gene expression visible. Additionally, the small interfering RNA (siRNA) approach was tested as another strategy to inhibit expression of the pro-inflammatory chemokines MCP-1 and RANTES. Two different methods were pursuit, describing transient transfection with vector derived and synthetic siRNA. The vector pSUPER containing the siRNA coding sequence was used to suppress endogenous MCP-1 in HEK 293 cells. An empty vector without RNA sequence served as a control. Inhibition due to the siRNA was measured in stimulated and unstimulated cells. In TNF-a stimulated cells MCP-1 protein synthesis was decreased by 35 ± 11% after siRNA transfection. Using a synthetic double-stranded siRNA, the TNF-a induced MCP-1 protein secretion could be successfully inhibited about 62.3 ± 10.3% in HEK 293 cells, indicating that the siRNA is functional in these cells to suppress chemokine expression. The siRNA approach targeting murine RANTES in Th1 cells and b-end3 cells revealed no inhibition of endogenous gene expression. Gene therapy approaches rely on efficient transfer of genes to the desired target cells. A wide variety of viral and nonviral vectors have been developed and evaluated for their efficiency of transduction, sustained expression of the transgene, and safety. Among them, lentiviruses have been widely used for gene therapy applications. In order to improve the delivery of TFOs or siRNAs into the target cells, cloning of the lentiviral transfer vector SEW, the production of lentiviral particles by transient transfection were performed with the aim to generate lentiviral vector-derived TFOs in further experiments. Here, Th1 cells were transduced with infectious lentiviral particles and transduction efficacy was measured. Transduction efficacy higher than 82% could be achieved using the lentiviral vector SEW, opening optimal possibilities for the TFO or siRNA approach.
Jet physics in ALICE
(2005)
This work aims at the performance of the ALICE detector for the measurement of high-energy jets at mid-pseudo-rapidity in ultra-relativistic nucleus-nucleus collisions at LHC and their potential for the characterization of the partonic matter created in these collisions. In our approach, jets at high energy with E_{T}>50 GeV are reconstructed with a cone jet finder, as typically done for jet measurements in hadronic collisions. Within the ALICE framework we study its capabilities of measuring high-energy jets and quantify obtainable rates and the quality of reconstruction, both, in proton-proton and in lead-lead collisions at LHC conditions. In particular, we address whether modification of the jet fragmentation in the charged-particle sector can be detected within the high particle-multiplicity environment of the central lead-lead collisions. We comparatively treat these topics in view of an EMCAL proposed to complete the central ALICE tracking detectors. The main activities concerning the thesis are the following: a) Determination of the potential for exclusive jet measurements in ALICE. b) Determination of jet rates that can be acquired with the ALICE setup. c) Development of a parton-energy loss model. d) Simulation and study of the energy-loss effect on jet properties.
Acute myeloid leukemia (AML) is characterized by the accumulation of a large number of abnormal, immature blast cells. Recently, histone deacetylase inhibitors (HDIs) received considerable interest on the ground of their ability to overcome the differentiation block in these leukemic blasts regardless of the primary genetic alteration, an effect achieved either alone or in combination with differentiating agents, such as all-trans retinoic acid (t-RA). Valproic acid (VPA), a potent HDI, is now under clinical evaluation owing to its potent differentiation effect on transformed hematopoietic progenitor cells and leukemic blasts from AML patients. Conversely, in a clinical study by Bug et al., the favorable effects of the combination treatment with t-RA/VPA in advanced acute myeloid leukemia patients were reported to be most likely due to an enhancement of nonleukemic myelopoiesis and the suppression of malignant hematopoiesis rather than enforced differentiation of the leukemic cells. Based on the hypothesis that VPA influences normal hematopoiesis, the effect of chromatin modeling through VPA on HSCs was investigated with respect to differentiation, proliferation as well as self-renewal in the present study. It has been shown that valproic acid increases both proliferation and self-renewal of HSC. It accelerates cell cycle progression of HSC accompanied by a down-regulation of p21cip-1/waf-1. Furthermore, valproic acid inhibits GSK3B by phosphorylation on Ser9 accompanied by an activation of the Wnt signaling pathway as well as by an up-regulation of HoxB4, a target gene of Wnt signaling. Both are known to directly stimulate the proliferation of HSC and to expand the HSC pool. To sum up, valproic acid, a potent histone deacetylase inhibitor known to induce differentiation and/or apoptosis in leukemic blasts, stimulates the proliferation and self-renewal of hematopoietic stem cells. Therefore, the data reported in this study suggest to reconsider the role of histone deacetylase inhibitors from a differentiation inducer to a coadjuvant factor for increasing the response to conventional therapy in acute myeloid leukemia.
One possible approach to study systematically the influence of the deformation regime on the geometry of geological structures like folds and boudins is analogue modelling. For a complete understanding of the resulting structures, consideration of the third dimension is required. This PhD study deals with scaled analogue modelling under constriction and plane-strain conditions to improve our knowledge of folding and boudinage of lower crustal rocks in space and time. Plasticine is an appropriate analogue material for rocks in the lower crust. Therefore, this material was used for the experiments. The macroscopic behaviour of most types of plasticine is quite similar to rocks undergoing strain-rate softening and strain hardening regardless of the different microscopic aspects of deformation. Therefore, if one is aware that the stress exponent and viscosity increase with increasing strain, the original plasticine types used with stress exponents ranging from 5.8 to 8.0 are adequate for modelling geologic structures. The same holds for plasticine/oil mixtures. Thus, plasticine and plasticine/oil mixtures can be used to model the viscous flow of different rock types in the lower crust. If climb-accommodated dislocation creep and associated steady-state flow is assumed for the natural rocks, the plasticine/oil mixtures should be used, which flow under steady-state conditions. Three different experimental studies of plane-strain coaxial deformation of stiff layers, with viscosity η2 and stress exponent n2, embedded in a weak matrix, with viscosity η1 and stress exponent n1, have been carried out. The undeformed samples (matrix plus layer) were cubes with an edge length of 12 cm. All experimental runs have been carried out at T = 25 ± 1°C and varying strain rates ė, ranging from 7.9 x 10 high -6 s high -1 to 1.7 x 10 high -2 s high -1, until a finite longitudinal strain of 30% – 40% was achieved. The first experimental study improved the understanding about the evolution of folds and boudins when the layer is oriented perpendicular to the Y-axis of the finite strain ellipsoid. The rock analogues used were Beck’s green plasticine (matrix) and Beck’s black plasticine (competent layer), both of which are strain-rate softening modelling materials with stress exponent n = ca. 8. The effective viscosity η of the matrix plasticine was changed by adding different amounts of oil to the original plasticine. At a strain rate ė of 10 high -3 s high -1 and a finite strain e of 10%, the effective viscosity of the matrix ranges from 1.2 x 10 high 6 to 7.2 x 10 high 6 Pa s. The effective viscosity of the competent layer has been determined as 4.2 x 10 high 7 Pa s. If the viscosity ratio is large (> ca. 20) and the initial thickness of the competent layer is small, both folds and boudins develop simultaneously. Although the growth rate of the folds seems to be higher than the growth rate of the boudins, the wavelength of both structures is approximately the same as is suggested by analytical solutions. A further unexpected, but characteristic, aspect of the deformed competent layer is a significant increase in thickness, which can be used to distinguish plane-strain folds and boudins from constrictional folds and boudins. In the second experimental study, the impact of varying strain rates on growing folds and boudins under plane strain have been investigated. The strain rates used range from 7.9 x 10 high -6 s high -1 to 1.7 x 10 high -2 s high -1. The stiff layer and matrix consist of non-linear viscous Kolb grey and Beck’s green plasticine, respectively, both of which are strain-rate softening modelling materials with power law exponents (n) and apparent viscosities (η) ranging from 6.5 to 7.9 and 8.5 x 10 high 6 to 7.2 x 10 high 6 Pa s, respectively. The effective viscosity (η) of the matrix plasticine was partly modified by adding oil to the original plasticine. At the strain rates used in the experiments the viscosity ratio between layer and matrix ranges between 3 and 10. Different runs have been carried out where the layer was oriented perpendicular to the principal strain axes (X>Y>Z). The results suggest a considerable influence of the strain rate on the geometry of the deformed stiff layer including its thickness. This holds for every type of layer orientation (S ┴ X, S ┴ Y, S ┴ Z). If the stiff layer is oriented perpendicular to the short axis Z of the finite strain ellipsoid, the number of the resulting boudins and the thickness of the stiff layer increase, whereas the length of boudins decreases with increasing strain rate. If the stiff layer is oriented perpendicular to the long axis, X, of the finite strain ellipsoid, enlargement of the strain rate results in increasing wavelength of folds, whereas the number of folds and the degree of thickening of the stiff layer decreased. If the stiff layer is oriented perpendicular to the intermediate Y-axis of the finite strain ellipsoid enlargement of the strain rate results in a decreasing number of boudins and folds associated with increasing wavelengths of both structures. The wavelength of folds is approximately half of the boudins wavelength. This is true for the case where folds and boudins develop simultaneously (S ┴ Y) and for cases where both structures develop independently (folds at S ┴ X and boudins at S ┴ Z). In the third experimental study, scaled analogue experiments have been carried out to demonstrate the growth of plane-strain folds and boudins through space and time. Previous 3D-studies are based only on finite deformation structures. Their results can therefore not be used to prove if both structures grew simultaneously or in sequence. Plane strain acted on a single stiff layer that was embedded in a weak matrix, with the layer oriented perpendicular to the intermediate Y-axis of the finite strain ellipsoid. Two different experimental runs have been carried out using computer tomography (CT) to analyse the results. The first run was carried out without interruption. During the second run, the deformation was stopped in each case at longitudinal strain increments of 10%. Every experiment was carried out at a temperature T of 25°C and a strain rate, ė, of ca. 4 x 10 high -3 s high -1 until a finite longitudinal strain of 40% was achieved with a viscosity contrast m of 18.6 between the non-linear viscous layer (Kolb brown plasticine) and the matrix (Beck’s green plasticine with 150 ml oil kg high -1). The apparent viscosity, η, and the stress exponent, n, for the layer at a strain rate ė = ca. 10 high -3 s high -1 and a finite strain e = 10% are 2.23 x 10 high 7 Pa s and n = 5.8 and for the matrix 1.2 x 10 high 6 Pa s and 10.5. These new data that result from incremental analogue modelling corroborate previous suggestions that folds and boudins are coeval structures in cases of plane-strain coaxial deformation with the stiff layer oriented perpendicular to the intermediate Y-axis of the finite strain ellipsoid. They will be of interest for all workers who are dealing with plane-strain boudins and folds, where the fold axes are parallel to the major axis (X) of the finite strain ellipsoid. As has been demonstrated by the first experimental study, coeval folding and boudinage under plane strain, with S ┴ Y, are associated with a significant increase in the thickness of the competent layer. The latter phenomenon does not occur in other cases of simultaneous folding and boudinage, such as bulk pure constriction. To study the impact of layer thickness on the geometry of folds and boudins under pure constriction, we carried out additional experiments using different types of plasticine for a stiff layer and a weaker matrix to model folding and boudinaging under pure constriction, with the initially planar layer oriented parallel to the Xaxis of the finite strain ellipsoid. The stiff layer and matrix consist of non-linear viscous Kolb brown and Beck’s green plasticine, respectively, both of which are strain-rate softening modelling materials. Six runs have been carried out using thicknesses of the stiff layer of 1, 2, 4, 6, 8 and 10 ± 0.2 mm. All experimental runs were carried out at a temperature T of 30 ± 2°C and a strain rate, ė, of ca. 1.1 x 10 high -4 s high -1 until a finite longitudinal strain of 40% was achieved with a viscosity contrast m of 3.1 between the stiff layer (Kolb brown plasticine) and the matrix (Beck’s green plasticine). The apparent viscosity, η, and the stress exponent, n, for the layer at a strain rate ė = ca. 10 high -3 s high -1 and a finite strain e = 10% are 2.23 x 10 high 7 Pa s and n = 5.8 and for the matrix 7.2 x 10 high 6 Pa s and 7.9. Our results suggest a considerable influence of the initial thickness of the stiff layer on the geometry of the deformed stiff layer. There is no evidence for folding in XY=XZ-sections if the initial thickness of the competent layer is larger than ca. 8 mm. If the initial thickness of the competent layer is set at ca. 10 ± 0.2 mm, both folds and boudins develop simultaneously. However, the growth rate of the boudins seems to be higher than the growth rate of the folds. A further expected, but characteristic, aspect of the deformed competent layer is no change in thickness of the competent layer, which can be used to distinguish plane-strain folds and boudins from constrictional folds and boudins. The model results are important for the analysis and interpretation of deformation structures in rheologically stratified rocks undergoing dislocation creep under bulk constriction. Tectonic settings where constrictional folds and boudins may develop simultaneously are stems of salt diapirs, subduction zones or thermal plumes. To make (paleo) viscosimetric statements possible, the rheological data of the different plasticine types were related to the geometrical data. When comparing the normalized dominant wavelength Wd obtained from the deformed layer of the models with the theoretical dominant wavelength (Ld) calculated using the Smith equation (1977, 1979), the latter probably also holds when folding and boudinage develop simultaneously (S ┴ Y) and when boudins develop independently (S ┴ Z), but can obviously not be applied at very low viscosity ratios as is indicated by the low-strain-rate experiments.
In the present work, the Heidelberg electron beam ion trap (EBIT) at the Max-Planck-Institute für Kernphysik (MPIK) has been used to produce, trap highly charged argon ions and study their magnetic dipole (M1) forbidden transitions. These transitions are of relativistic origin and, hence, provide unique possibilities to perform precise studies of relativistic effects in many electron systems. In this way, the transitions energies of the 1s22s22p for the 2P3/2 - 2P1/2 transition in Ar13+ and the 1s22s2p for the 3P1 - 3P2 transition in Ar14+, for 36Ar and 40Ar isotopes were compared. The observed isotopic effect has confirmed the relativistic nuclear recoil effect corrections due to the finite nuclear mass in a recent calculation made by Tupitsyn [TSC03], in which major inconsistencies of earlier theoretical methods have been corrected for the first time. The finite mass, or recoil effect, composed of the normal mass shift (NMS), and the specific mass shift (SMS) were corrected for relativistic contributions, RNMS and RSMS. The present experimental results have shown that the recoil effects on the Breit level are indeed very important, as well as the effects of the correlated relativistic dynamics in a many electron ion.
G protein-coupled receptors (GPCRs) play regulatory roles in many different physiological processes and they represent one of the most important class of drug targets. However, due to the lack of three-dimensional structures, structure based drug design has not been possible. The major bottleneck in getting three-dimensional crystal structure of GPCRs is to obtain milligram quantities of pure, homogenous and stable protein. Therefore, during my Ph.D. thesis, I focused on expression, characterization and isolation of three GPCRs namely human bradykinin receptor subtype 2 (B2R), human angiotensin II receptor subtype 1 (AT1aR), and human neuromedin U receptor subtype 2 (NmU2R). These receptors were heterologously produced in three different expression systems (i.e. Pichia pastoris, insect cells and mammalian cells), biochemically characterized and subsequently solubilized and purified for structural studies The human bradykinin receptor subtype 2 (B2R) is constitutively expressed in a variety of cells, including endothelial cells, vascular smooth muscle cells and cardiomyocytes. Activation of B2R is important in pathogenesis of inflammation, pain, tissue injury and cardioprotective mechanisms. During this study, recombinant B2R was produced in methylotrophic yeast Pichia pastoris (3.5 pmol/mg), insect cells (10 pmol/mg) and mammalian cells (60 pmol/mg). The recombinant receptor was characterized in terms of [3H] bradykinin binding, G protein coupling, localization, and glycosylation. Subsequently, it was solubilized and purified using affinity chromatography. Homogeneity and stability of purified B2R was monitored by gel filtration analysis. Milligram amounts of pure and stable receptor were obtained from BHK cells and Sf9 cells, which were used for three-dimensional crystallization attempts. The second receptor, which I worked on, is human angiotensin II receptor subtype 1 (AT1aR). AT1aR is distributed in smooth muscle cells, liver, kidney, heart, lung and testis. Activation of AT1aR is implicated in the regulation of blood pressure, hypertension and cardiovascular diseases. Recombinant AT1aR was produced at high levels in Pichia pastoris (167 pmol/mg), while at moderate levels in insect cells (29 pmol/mg) and mammalian cells (32 pmol/mg). The recombinant receptor was characterized in terms of [3H] angiotensin II binding, localization, and glycosylation. Subsequently, the receptor was solubilized and purified using affinity chromatography. Homogeneity and stability of purified AT1aR was monitored by gel filtration analysis. Milligram amounts of pure and stable receptor were obtained from Pichia pastoris, which were used for threedimensional crystallization attempts. In addition to B2R and AT1aR, I also attempted to produce and isolate the human neuromedin U receptor subtype 2 (NmU2R), which was deorphanized recently. It is found in highest abundance in the central nervous system, particularly the medulla oblongata, spinal cord and thalamus. The distribution of this receptor suggests its regulatory role in sensory transmission and modulation. During this study, recombinant NmU2R was produced in Pichia pastoris (6 pmol/mg) and BHK cells (9 pmol/mg). Recombinant receptor was characterized with regard to [125I] NmU binding, localization and glycosylation. Subsequently, the receptor was solubilized and purified using affinity chromatography. Due to its low expression level, further expression optimization is required in order to obtain milligram amounts for structural studies. The long-term goal of this study was to obtain three-dimensional crystal structure of recombinant GPCRs. However, 3-dimensional crystallization of human recombinant membrane proteins still remains a difficult task. On the other hand, recent advances in the solid-state NMR spectroscopy offer ample opportunities to study receptor-ligand systems, provided milligram quantities of purified receptor are available. Therefore, in parallel to 3-dimensional crystallization trials, purified B2R was also used for solid-state NMR analysis in order to investigate the receptor bound conformation of bradykinin. Preliminary results are promising and indicate significant structural changes in bradykinin upon binding to B2R. Further experiments are ongoing and will hopefully result in the structure of receptor bound bradykinin. One of the challenges in GPCR crystallization is the small hydrophilic surface area that is available to make crystal contacts. One possibility to overcome this problem can be the reconstitution of a GPCR complex with an interacting protein for cocrystallization. For this purpose, I coexpressed B2R and AT1aR, which form a stable heterodimer complex, in BHK cells. I could successfully isolate the heterodimer complex by using two-step affinity purification. Unfortunately, this complex was not stable over time and disassociates within three days of purification. However, during coexpression of B2R and AT1aR in BHK cells, I observed that B2R was localized in the plasma membrane in coexpressing cells while it was retained intracellularly when expressed alone. This coexpression of AT1aR with B2R resulted in a four-fold increase in [3H] bradykinin binding sites on the cell surface. In addition, these two receptors were cointernalized in response to their individual specific ligands. Interestingly, colocalization of B2R and AT1aR was also found in human foreskin fibroblasts (which endogenously express both receptors), in line with the possibility that heterodimerization may be required for surface localization of B2R in native tissues as well. This is the first report where surface localization of a peptide GPCR is triggered by a distantly related peptide GPCR. These data support the hypothesis that heterodimerization may be a prerequisite for cell surface localization of some GPCRs. A second approach that I followed to stabilize the purified B2R was to reconstitute the B2R-β-arrestin complex. β-arrestin is a cytosolic protein that participates in agonist mediated desensitization of GPCRs and therefore dampens the cellular responses initiated by the activation of GPCRs. I tried to reconstitute B2R-β-arrestin complex in vitro by mixing purified B2R and purified β-arrestin. But, no interaction of these two proteins was observed in the pull-down assays. However, a C-terminal mutant of B2R (where a part of the C-terminus of the B2R is exchanged with that of the vasopressin receptor) was found to interact with β-arrestin in vitro as revealed by pull-down assays. In conclusion, this work establishes the production, characterization and isolation of three recombinant human GPCRs. Recombinant receptors were produced in milligram amounts and therefore, pave the way for structural analysis. The heterodimer complex of B2R-AT1aR and B2R-β-arrestin complex can be of great help during crystallization. In addition, it was also found for the first time that the surface localization of a peptide GPCR can be triggered by heterodimerization with a distantly related peptide GPCR.
Stem cells capable of self-renewal and differentiation into multiple tissues are important in medicine to reconstitute the hematopoietic system after myelo-ablative chemo- or radiotherapy. In the present situation, adult stem cells such as Mesenchymal stem cells (MSC) and Hematopoietic stem cells (HSC) are used for therapeutic purposes. For tissue regeneration and tissue constitution, engraftment of transplanted stem cells is a necessary feature. However, in many instances, the transplanted stem cells reach the tissues with low efficiency. Considering the three-step model of leukocyte extravasation by Springer et al, the rolling, adhesion and transmigration form the three major steps for the transplanted stem cells to enter the desired tissues. One of the molecular switches reported to be involved in these mechanisms are the Rho family GTPases. The present study investigates the role of Rho GTPases in adhesion and migration of stem and progenitor cells. Chemotactic and chemokinetic migration assays, transendothelial migration assays, migration of cells under shear stress, microinjection, retroviral and lentiviral gene transfer methods, oligonucleotide microarray analysis and pull down assays were employed in this study for the elucidation of Rho GTPase involvement in migration and adhesion of stem and progenitor cells. The transmigration assay used for the migration determination of the adherent cell type, MSC, was optimized for the efficient and effective assessment of the migrating cells. The involvement of Rho was found to be critical for stem and progenitor cell migration where inactivation of Rho by C2I-C3 transferase toxin and/or overexpression of C3 transferase cDNA increased the migration rate of Hematopoietic progenitor cells (HPC) and MSC. Moreover, modulation of Rho caused predictable cytoskeletal and morphological changes in MSC. Assessment of Rho GTPase involvement in the interacting partner, the endothelial cells during stem cell migration, revealed that active Rho expression induced E-selectin expression. The increased levels of E-selectin were functionally confirmed by the increased adhesion of progenitor cells (HPC) to the Human umbilical vein endothelial cell (HUVEC) layer. Moreover, inhibition of Rac in the migrating endothelial progenitor cells (eEPC) increased their adhesion to HUVEC correlating with the increased percentage expression of cell surface receptor, CD44 in Rac inactivated eEPC. In conclusion, this study shows that Rho GTPases control the adhesion and migration of stem and progenitor cells, HPC and MSC. Rho inhibition drives the cells to migrate in the blood vessels. The substantial increase in the level of active Rho in endothelial layer, manifested by the E-selectin surface expression assists the better adhesion of stem and progenitor cells to the endothelial layer. Serum factors and growth factors in the physiological system influence the Rho GTPase expression in both migrating stem cells and the barrier endothelial cells. Thus, specific modulation of Rho GTPases in the transplanted stem and progenitor cells could be an interesting tool to improve the migration and homing processes of stem cells for cellular therapy in future.